Acumen Pharmaceuticals shares fall 75% premarket
Acumen Pharmaceuticals (ABOS) shares fell 75% before the market open.
Related stories
Lockheed Martin Shares Hit 32-week High
Lockheed Martin shares increased to 650.03 USD, the highest since March 2026. Over the past 4 weeks, Lockheed Martin gained 27.24%, and in the last 12 months, it increased 32.32%.
L impact | EQUITY | Oct 30, 2026, 01:34 PM UTC
Nasdaq Composite Falls 633.70 Points (2.42%)
M impact | EQUITY | Oct 30, 2026, 01:33 PM UTC
S&P 500 Falls 96.23 Points, or 1.25%
M impact | EQUITY | Oct 30, 2026, 01:33 PM UTC
AbbVie Reports Q3 2026 Revenue of $17.4 Billion, Up 10.3%
AbbVie said Q3 2026 revenue rose 10.3% year over year to $17.4 billion, in line with estimates. Non-GAAP profit was $3.82 per share, 1.3% above analysts’ consensus.
H impact | EQUITY | Oct 30, 2026, 01:32 PM UTC
Chubb Shares Hit All-time High
Chubb shares increased to an all-time high of 368.10 USD. Over the past 4 weeks, Chubb gained 13.18%, and in the last 12 months, it increased 32.39%.
L impact | EQUITY | Oct 30, 2026, 01:30 PM UTC
Nvidia Shares Hit 9-week Low
Nvidia shares decreased to 208.60 USD, the lowest since August 2026. Over the past 4 weeks, Nvidia Corporation lost 6.47%, and in the last 12 months, it increased 5.28%.
L impact | EQUITY | Oct 30, 2026, 01:30 PM UTC